MEDICAL DEVICE SYSTEM

• US 20130204103A1
• Filed: 12/06/2010
• Published: 08/08/2013
• Est. Priority Date: 12/08/2009
• Status: Abandoned Application

• Current Assignee: Albert Maarek
• Original Assignee: Albert Maarek
• Inventors: Maarek, Albert
• Application Number:
  US13/514,353
• Publication Number:
  US 20130204103A1
• Time in Patent Office: Days
• US Class Current: 600/323
• CPC Class Codes: A61B 5/02225 using the oscillometric method
• CPC Class Codes: A61B 5/02405 Determining heart rate variability
• CPC Class Codes: A61B 5/02416 using photoplethysmograph signals, e.g. generated by infrared radiation A61B5/14552 takes precedence
• CPC Class Codes: A61B 5/0245 by using sensing means generating electric signals, i.e. ECG signals
• CPC Class Codes: A61B 5/053 Measuring electrical impedance or conductance of a portion of the body
• CPC Class Codes: A61B 5/0531 Measuring skin impedance
• CPC Class Codes: A61B 5/091 Measuring volume of inspired or expired gases, e.g. to determine lung capacity
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/14551 for measuring blood gases
• CPC Class Codes: A61B 5/318 Heart-related electrical modalities, e.g. electrocardiography [ECG]
• CPC Class Codes: A61B 5/4872 Body fat

Abstract

The invention provides a medical device system comprising at least two technologies wherein at least one technology is based on bio-impedance measuring and/or at least one technology is based on spectrophotometry measurements wherein software cross analyses the results to assess the homeostasis of an individual. The technologies measure a variety of parameters. In one embodiment the bioimpedance measuring equipment measures in bipolar mode and in tetrapolar mode and the spectophotmeter measuring equipment comprises a pulse oximeter. The system and homeostasis score can be used to determine and monitor therapy for a patient.

Claims

1. A medical device system comprising at least two technologies wherein at least one technology is based on bio-impedance measuring and/or at least one technology is based on spectrophotometry measurements wherein software cross analyses the results to assess the homeostasis of an individual.

2. A system as claimed in claim 1 wherein a series of medical devices measure a variety of parameters using different technologies and software compiles the results of these to provide a homeostasis score.

3. A system as claimed in claim 1 comprising at least a pulse oximeter which provides a vascular waveform in combination with other biosensors and software.

4. A system as claimed in claim 1 which further includes EKG monitor, blood glucose meter, spirometer.

5. A system as claimed in claim 1 comprising at least 4 biosensors wherein signal processing-analysis is managed by software.

6. A system as claimed in claim 5 wherein the technologies include a) bioimpedance in bipolar mode (ElS sensor), b) bioimpedance in tetrapolar mode (ES-BC sensor), c) a spectrophotometer (ESO sensor) and d) oscillometric measurements. (NlBP sensor)

7. Use of a system as claimed in claim 1 to establish a homeostasis score for a patient.

8. A medical device system to assess the homeostasis of an individual, the system comprising bio impedance measuring equipment and spectophometry measuring equipment and software capable of analyzing both sets of results.

9. A medical device system as claimed in claim 8 wherein the bioimpedance measuring equipment measures bioimpedance in bipolar mode and in tetrapolar mode.

10. A medical device system as claimed in claim 9 wherein the spectophotmeter measuring equipment comprises a pulse oximeter.

11. A medical device system as claimed in claim 8 wherein the software analyzes the results to calculate assess a patient and provides the results as a homeostasis score.

12. A score of homeostasis of an individual comprising a series of defined tests including at least bioimpedance and spectrophotometer monitoring.